Jeff DeFalco

1.2k total citations
11 papers, 828 citations indexed

About

Jeff DeFalco is a scholar working on Sensory Systems, Nutrition and Dietetics and Biochemistry. According to data from OpenAlex, Jeff DeFalco has authored 11 papers receiving a total of 828 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Sensory Systems, 4 papers in Nutrition and Dietetics and 3 papers in Biochemistry. Recurrent topics in Jeff DeFalco's work include Ion Channels and Receptors (6 papers), Biochemical Analysis and Sensing Techniques (4 papers) and Phytochemicals and Antioxidant Activities (3 papers). Jeff DeFalco is often cited by papers focused on Ion Channels and Receptors (6 papers), Biochemical Analysis and Sensing Techniques (4 papers) and Phytochemicals and Antioxidant Activities (3 papers). Jeff DeFalco collaborates with scholars based in United States and United Kingdom. Jeff DeFalco's co-authors include Xiaoli Cai, Jeffrey M. Friedman, Daniel Emerling, Matthew A. J. Duncton, Hongyan Liu, Jamey D. Marth, Mark Tomishima, Connie Zhao, Lynn W. Enquist and Michael Kelly and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

Jeff DeFalco

9 papers receiving 811 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeff DeFalco United States 8 267 234 190 169 143 11 828
Sílvia Pinto Belgium 16 457 1.7× 71 0.3× 184 1.0× 189 1.1× 233 1.6× 30 806
Chun‐Hsiang Tan Taiwan 16 209 0.8× 36 0.2× 130 0.7× 122 0.7× 138 1.0× 36 734
Eva Tsaousidou Germany 8 96 0.4× 218 0.9× 116 0.6× 174 1.0× 92 0.6× 9 662
Isaías Glezer Brazil 20 129 0.5× 46 0.2× 388 2.0× 253 1.5× 222 1.6× 37 1.3k
Shigeyoshi Fuziwara Japan 11 425 1.6× 75 0.3× 191 1.0× 196 1.2× 184 1.3× 11 866
Eduardo Sainz United States 18 491 1.8× 105 0.4× 518 2.7× 81 0.5× 419 2.9× 39 1.5k
Jiehong Huang China 16 551 2.1× 101 0.4× 419 2.2× 571 3.4× 443 3.1× 36 1.4k
Koji Fukagawa Japan 24 279 1.0× 725 3.1× 332 1.7× 289 1.7× 165 1.2× 44 1.5k
Pilar Fernández‐Mateos Spain 16 67 0.3× 271 1.2× 189 1.0× 301 1.8× 42 0.3× 30 801
Thomas F.J. Wagner Germany 8 607 2.3× 31 0.1× 368 1.9× 151 0.9× 205 1.4× 8 933

Countries citing papers authored by Jeff DeFalco

Since Specialization
Citations

This map shows the geographic impact of Jeff DeFalco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeff DeFalco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeff DeFalco more than expected).

Fields of papers citing papers by Jeff DeFalco

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeff DeFalco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeff DeFalco. The network helps show where Jeff DeFalco may publish in the future.

Co-authorship network of co-authors of Jeff DeFalco

This figure shows the co-authorship network connecting the top 25 collaborators of Jeff DeFalco. A scholar is included among the top collaborators of Jeff DeFalco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeff DeFalco. Jeff DeFalco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
2.
Benjamin, Jonathan, Nicholas Higgins, Carl Millward, et al.. (2020). First-in-human phase Ib study of ATRC-101, an engineered version of a patient-derived antibody targeting a tumor-restricted ribonucleoprotein complex.. Journal of Clinical Oncology. 38(15_suppl). TPS3168–TPS3168.
3.
Nguyen, Margaret, Donogh J. R. O’Mahony, Qingling Zhang, et al.. (2015). Identification of orally-bioavailable antagonists of the TRPV4 ion-channel. Bioorganic & Medicinal Chemistry Letters. 25(18). 4011–4015. 29 indexed citations
4.
DeFalco, Jeff, Margaret Nguyen, Matthew A. J. Duncton, et al.. (2012). Discovery of potent, non-carbonyl inhibitors of fatty acid amide hydrolase (FAAH). MedChemComm. 3(10). 1258–1258. 7 indexed citations
5.
DeFalco, Jeff, Matthew A. J. Duncton, & Daniel Emerling. (2011). TRPM8 Biology and Medicinal Chemistry. Current Topics in Medicinal Chemistry. 11(17). 2237–2252. 25 indexed citations
6.
Stanley, Sarah A., Shirly Pinto, Jeremy Segal, et al.. (2010). Identification of neuronal subpopulations that project from hypothalamus to both liver and adipose tissue polysynaptically. Proceedings of the National Academy of Sciences. 107(15). 7024–7029. 154 indexed citations
7.
DeFalco, Jeff, et al.. (2010). 5-Benzyloxytryptamine as an antagonist of TRPM8. Bioorganic & Medicinal Chemistry Letters. 20(23). 7076–7079. 24 indexed citations
8.
DeFalco, Jeff, et al.. (2009). Oxime derivatives related to AP18: Agonists and antagonists of the TRPA1 receptor. Bioorganic & Medicinal Chemistry Letters. 20(1). 276–279. 50 indexed citations
9.
Vincent, Fabien, Margaret Nguyen, Michelle Dourado, et al.. (2009). Identification and characterization of novel TRPV4 modulators. Biochemical and Biophysical Research Communications. 389(3). 490–494. 188 indexed citations
10.
Emerling, Daniel, et al.. (2009). Functional Assessment of Temperature-Gated Ion-Channel Activity Using a Real-Time PCR Machine. BioTechniques. 47(sup3). iii–ix. 18 indexed citations
11.
DeFalco, Jeff, Mark Tomishima, Hongyan Liu, et al.. (2001). Virus-Assisted Mapping of Neural Inputs to a Feeding Center in the Hypothalamus. Science. 291(5513). 2608–2613. 333 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026